Inviting an author to review:
Find an author and click ‘Invite to review selected article’ near their name.
Search for authorsSearch for similar articles
25
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      High-accuracy determination of internal circadian time from a single blood sample

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <p class="first" id="d4360706e380"> <b>BACKGROUND.</b> The circadian clock is a fundamental and pervasive biological program that coordinates 24-hour rhythms in physiology, metabolism, and behavior, and it is essential to health. Whereas therapy adapted to time of day is increasingly reported to be highly successful, it needs to be personalized, since internal circadian time is different for each individual. In addition, internal time is not a stable trait, but is influenced by many factors, including genetic predisposition, age, sex, environmental light levels, and season. An easy and convenient diagnostic tool is currently missing. </p><p id="d4360706e385"> <b>METHODS.</b> To establish a validated test, we followed a 3-stage biomarker development strategy: (a) using circadian transcriptomics of blood monocytes from 12 individuals in a constant routine protocol combined with machine learning approaches, we identified biomarkers for internal time; and these biomarkers (b) were migrated to a clinically relevant gene expression profiling platform (NanoString) and (c) were externally validated using an independent study with 28 early or late chronotypes. </p><p id="d4360706e390"> <b>RESULTS.</b> We developed a highly accurate and simple assay (BodyTime) to estimate the internal circadian time in humans from a single blood sample. Our assay needs only a small set of blood-based transcript biomarkers and is as accurate as the current gold standard method, dim-light melatonin onset, at smaller monetary, time, and sample-number cost. </p><p id="d4360706e395"> <b>CONCLUSION.</b> The BodyTime assay provides a new diagnostic tool for personalization of health care according to the patient’s circadian clock. </p><p id="d4360706e400"> <b>FUNDING.</b> This study was supported by the Bundesministerium für Bildung und Forschung, Germany (FKZ: 13N13160 and 13N13162) and Intellux GmbH, Germany. </p><p class="first" id="d4360706e406"> <div class="figure-container so-text-align-c"> <img alt="" class="figure" src="/document_file/932a6d91-da66-43d6-bf8d-600e833a82f8/PubMedCentral/image/jci-128-120874-g165.jpg"/> </div> </p>

          Related collections

          Author and article information

          Journal
          Journal of Clinical Investigation
          American Society for Clinical Investigation
          1558-8238
          June 28 2018
          June 28 2018
          Article
          10.1172/JCI120874
          6118629
          29953415
          89aa1466-df43-44c6-bde1-24f03d904475
          © 2018
          History

          Comments

          Comment on this article